Alar Financial Statements From 2010 to 2024
| 6785 Stock | TWD 146.00 3.50 2.34% |
Check Alar Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alar Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Alar financial statements analysis is a perfect complement when working with Alar Pharmaceuticals Valuation or Volatility modules.
Alar |
Alar Pharmaceuticals Company Price To Book Analysis
Alar Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Alar Pharmaceuticals Price To Book | 4.97 X |
Most of Alar Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alar Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Alar Pharmaceuticals has a Price To Book of 4.97 times. This is 80.65% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to book for all Taiwan stocks is 47.74% higher than that of the company.
Alar Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alar Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Alar Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alar Pharmaceuticals competition to find correlations between indicators driving Alar Pharmaceuticals's intrinsic value. More Info.Alar Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alar Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Alar Pharmaceuticals Financial Statements
Alar Pharmaceuticals investors use historical fundamental indicators, such as Alar Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Alar Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Alar Pharmaceuticals Inc. operates as a drug development company. The company was founded in 2016 and is based in Taichung, Taiwan. ALAR PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 19 people.
Pair Trading with Alar Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alar Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Alar Stock
| 0.88 | 4114 | Synmosa Biopharma | PairCorr |
| 0.72 | 6576 | Foresee Pharmaceuticals | PairCorr |
| 0.85 | 6620 | Handa Pharmaceuticals | PairCorr |
Moving against Alar Stock
| 0.78 | 2345 | Accton Technology Corp | PairCorr |
| 0.57 | 1591 | Inmax Holding | PairCorr |
| 0.57 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.51 | 1795 | Lotus Pharmaceutical | PairCorr |
| 0.51 | 6674 | Compal Broadband Networks | PairCorr |
The ability to find closely correlated positions to Alar Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alar Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alar Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alar Pharmaceuticals to buy it.
The correlation of Alar Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alar Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alar Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alar Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Alar Stock Analysis
When running Alar Pharmaceuticals' price analysis, check to measure Alar Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alar Pharmaceuticals is operating at the current time. Most of Alar Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alar Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alar Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alar Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.